"Persisting gaps in M-OUD coverage at post-discharge recovery houses necessitate our continued advocacy"
Abstract
Effective treatment of opioid use disorder (OUD) must target both the medical and psychosocial aspects of a patient's condition. This, in turn, requires a collaboration between medical providers and social supports. We would like to illustrate a key difficulty in this collaboration for some patients in our country: many post-discharge recovery houses continue to refuse to allow patients to remain on medication treatment for OUD (M-OUD). This barrier to M-OUD access in recovery houses is a significant obstacle to effective OUD treatment.
https://www.tandfonline.com/eprint/ZF37INNUD7IEY3ZTJZGQ/full?target=10.1080/08897077.2019.1695038
Keywords: Medication assisted treatment, recovery homes, recovery houses, post-discharge, buprenorphine, Tennessee, transitional care facilities, homelessness
